Indefinite Delivery Contract 36E79720D0064

Award Date 10/31/20
Last Date to Order 10/30/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV award to Exelan Pharmaceuticals Inc., a foreign-owned pharmaceutical company based in Florida, is a single-award Indefinite Delivery Contract (IDC) valued at up to $28,235,184.10. The contract was awarded by the Defense Logistics Agency, a defense agency, with no set-aside designations, allowing Exelan to compete openly. The contract encompasses the delivery of a wide range of generic pharmaceutical products to federal healthcare agencies such as the Department of...
The federal contract IDV award SPE2D219D0070 was granted to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The IDV is a single-award indefinite delivery contract with a ceiling value of $45,158,494.05 and an ultimate completion date of May 28, 2024. Exelan Pharmaceuticals, a key supplier of generic and branded pharmaceutical products to various federal healthcare agencies, will deliver a diverse range of pharmaceutical items...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted IDC has a ceiling value of $4,792,297.44 and a period of performance through December 19, 2025. The contract covers the delivery of a variety of generic pharmaceutical products, including Dofetilide Capsules, to the VA, Department of...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a division of the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted contract has a ceiling value of $18,098,362.00 and a period of performance from March 2, 2021 to March 1, 2026. The contract is for the delivery of Pregabalin capsules, a generic pharmaceutical product, to the VA,...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract, valued at a ceiling of $8,974,952.04, is for the delivery of Zonisamide capsules in various strengths to the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The contract has a base period of one year from June...
This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,379,933.80 and a period of performance from October 27, 2022 to October 26, 2025, with four one-year option periods. The contract is for the delivery of Sildenafil Citrate tablets in various strengths and package sizes to support the medication needs of the...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award contract, valued at a ceiling of $12,802,166.10, is for the delivery of Ramipril capsules in various strengths and package sizes. The period of performance is from March 14, 2022, to March 13, 2023, with four one-year option periods. The...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The $29,031,544.57 IDC covers the delivery of a wide range of branded and generic pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service through August 2029. Key items include medications such as ibuprofen, citalopram, albuterol,...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award, unrestricted Indefinite Delivery Contract (IDC) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract, valued at a ceiling of $48,442,917.75, is for the supply of Escitalopram Oxalate Tablets in various package sizes to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The single-award IDC, valued at up to $6,984,109.81, has an ultimate completion date of February 11, 2029. Under this contract, Exelan Pharmaceuticals will provide a variety of generic pharmaceutical products to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through...

The federal contract IDV award is for the delivery of Topiramate tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The single-award, unrestricted contract was issued by the VA National Acquisition Center, with a total ceiling value of $32,360,809.00 and a period of performance from October 31, 2020 to October 30, 2025.

The prime contractor, Exelan Pharmaceuticals Inc., is a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida that specializes in manufacturing and distributing generic and branded pharmaceutical products to various federal healthcare agencies. The contract enables Exelan to provide an uninterrupted supply of Topiramate tablets in a range of dosages and package sizes to support the VA's and DoD's Pharmaceutical Prime Vendor Programs. The annual estimated requirements total over 200,000 bottles of Topiramate across multiple dose strengths, with the largest quantities for the 25mg and 100mg tablets.

Generated 4/12/25, 10:51 AM